НовостиBenzingaCanaccord Genuity Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $28 Canaccord Genuity Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $28 Benzinga 2026.10.14 12:14 (GMT+0) Открыть на Benzinga Другие новости